Your browser is no longer supported. Please, upgrade your browser.
Settings
GTXI GTX Inc. daily Stock Chart
GTXI [NASD]
GTX Inc.
Index- P/E- EPS (ttm)-0.36 Insider Own29.70% Shs Outstand140.39M Perf Week5.37%
Market Cap220.41M Forward P/E- EPS next Y-0.36 Insider Trans0.46% Shs Float33.42M Perf Month41.44%
Income-32.80M PEG- EPS next Q-0.04 Inst Own10.30% Short Float5.82% Perf Quarter124.29%
Sales- P/S- EPS this Y28.40% Inst Trans-1.84% Short Ratio7.91 Perf Half Y115.07%
Book/sh0.11 P/B14.27 EPS next Y-157.10% ROA-101.70% Target Price- Perf Year9.03%
Cash/sh0.32 P/C4.94 EPS next 5Y0.00% ROE-219.50% 52W Range0.41 - 1.59 Perf YTD115.07%
Dividend- P/FCF- EPS past 5Y17.70% ROI- 52W High-1.26% Beta1.99
Dividend %- Quick Ratio1.50 Sales past 5Y- Gross Margin- 52W Low282.93% ATR0.08
Employees25 Current Ratio1.50 Sales Q/Q- Oper. Margin- RSI (14)71.78 Volatility5.78% 6.04%
OptionableYes Debt/Eq0.00 EPS Q/Q85.70% Profit Margin- Rel Volume1.12 Prev Close1.51
ShortableYes LT Debt/Eq0.00 EarningsAug 05 BMO Payout- Avg Volume245.76K Price1.57
Recom3.00 SMA2013.44% SMA5041.19% SMA20098.99% Volume275,570 Change3.97%
Apr-05-13Initiated Stifel Buy $7
Oct-14-11Initiated Rodman & Renshaw Mkt Outperform $7
Jul-20-11Initiated Wedbush Outperform $13
Oct-27-10Upgrade Rodman & Renshaw Mkt Underperform → Mkt Perform
May-26-10Reiterated Rodman & Renshaw Mkt Underperform $1.75 → $1.25
Mar-17-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $1.75
Jan-26-09Reiterated Leerink Swann Mkt Perform $18 → $10
Jan-22-09Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
May-23-08Downgrade Cowen & Co Outperform → Neutral
Mar-25-08Initiated Rodman & Renshaw Mkt Outperform $22
Nov-07-07Reiterated Lazard Capital Buy $28 → $31
Nov-06-07Reiterated Broadpoint Capital Buy $26 → $29
Oct-11-07Initiated Wachovia Outperform
Sep-13-07Initiated First Albany Buy $26
May-10-07Initiated Citigroup Hold $24
Apr-30-07Downgrade Leerink Swann Outperform → Mkt Perform
Apr-24-07Reiterated HSBC Securities Overweight $25 → $29
Apr-18-07Reiterated Lazard Capital Buy $25 → $28
Apr-18-07Reiterated AG Edwards Buy $23 → $28
Feb-26-07Reiterated Lazard Capital Buy $21 → $25
Jun-30-15 10:35AM  Can the Uptrend Continue for GTx (GTXI)? - Tale of the Tape
Jun-23-15 01:20AM  Edited Transcript of GTXI earnings conference call or presentation 8-May-15 1:00pm GMT
Jun-09-15 08:34AM  Can The Uptrend Continue for GTx (GTXI)? - Tale of the Tape
Jun-02-15 06:31AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:00AM  GTx Regains Compliance with NASDAQ Bid Price Requirement Business Wire
May-26-15 07:00AM  GTx Announces Webcast of Corporate Presentation at Jefferies 2015 Global Healthcare Conference Business Wire
May-17-15 08:11PM  10-Q for GTx, Inc. at Company Spotlight
May-16-15 01:04PM  GTX INC /DE/ Financials
May-13-15 09:59AM  GTx (GTXI) Shares March Higher, Can It Continue? - Tale of the Tape
May-12-15 07:00AM  GTx Announces Webcast of Corporate Presentation at the UBS Global Healthcare Conference 2015 Business Wire
May-11-15 04:55PM  GTX INC /DE/ Files SEC form 10-Q, Quarterly Report
May-08-15 09:00AM  GTX Inc Earnings Call scheduled for 9:00 am ET today +11.84%
07:31AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:27AM  GTx reports 1Q loss
07:07AM  Q1 2015 GTX Inc Earnings Release - Before Market Open
07:00AM  GTx Provides Corporate Update and Reports First Quarter 2015 Financial Results Business Wire
Apr-30-15 02:33PM  3 Stocks Under $10 to Trade for Big Breakouts at TheStreet
Apr-23-15 07:34AM  GTx and the University of Tennessee Research Foundation Enter Into Exclusive License Agreement to Develop UTRFs SARD Drug Technology at noodls
07:32AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  GTx and the University of Tennessee Research Foundation Enter Into Exclusive License Agreement to Develop UTRFs SARD Drug Technology Business Wire
Apr-22-15 08:10PM  10-K for GTx, Inc. at Company Spotlight
Apr-17-15 05:02PM  GTX INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
Apr-02-15 07:31AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:15AM  GTx Provides Corporate Update Regarding NASDAQ Stock Listing at noodls
07:00AM  GTx Provides Corporate Update Regarding NASDAQ Stock Listing Business Wire
Mar-20-15 04:31PM  GTX INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran -5.26%
Mar-18-15 10:39AM  GIGABYTE Launches GeForceĀ® GTX TITAN X. The Most Advanced GPU Ever Built! at noodls
Mar-16-15 04:49PM  GTX INC /DE/ Files SEC form 10-K, Annual Report
Mar-13-15 09:00AM  ASUS' new gaming laptop packs NVIDIA's latest graphics card at Engadget
Mar-11-15 12:08AM  GTx, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast at noodls
12:08AM  GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results at noodls
Mar-05-15 11:12AM  GTX 960 processor increases Nvidias share in the gaming space +10.53%
07:53AM  Can the Rally in GTX Inc (GTXI) Shares Continue? - Tale of the Tape
Mar-04-15 04:32PM  GTX INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran -5.00%
09:00AM  GTX Inc Earnings Call scheduled for 9:00 am ET today
07:00AM  GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results Business Wire
Feb-19-15 05:01PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +13.64%
07:00AM  GTx, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast Business Wire
Feb-17-15 07:23AM  GTx Appoints Robert J. Wills, Ph.D. to Board of Directors at noodls
07:00AM  GTx Appoints Robert J. Wills, Ph.D. to Board of Directors Business Wire
Feb-12-15 05:12PM  Nvidia GeForce GTX 960 Review Part II: 1440p Benchmarks, 2-Way SLI, And Radeon 285 Showdown at Forbes
Jan-22-15 09:00AM  NVIDIA's newest GPU crams in tons of power without a hefty price at Engadget
Dec-15-14 06:29AM  Strength Seen in GTX Inc (GTXI): Stock Rises 10.6% Zacks +8.45%
Dec-08-14 08:00AM  GTx to Present Results on Enobosarm 9mg in Women with Metastatic Breast Cancer at 2014 San Antonio Breast Cancer Symposium Business Wire
Nov-21-14 07:07PM  10-Q for GTx, Inc. Company Spotlight
Nov-17-14 05:01PM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +7.27%
07:00AM  GTx Announces Closing of $43.4 Private Placement Business Wire
Nov-12-14 07:30AM  GTx Announces Webcast of Corporate Presentation at the Stifel 2014 Healthcare Conference Business Wire
Nov-10-14 05:23PM  GTX INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, EDGAR Online
09:00AM  GTX Inc Earnings Call scheduled for 9:00 am ET today CCBN
07:15AM  GTx Provides Corporate Update and Reports Third Quarter 2014 Financial Results Business Wire
07:00AM  GTx Announces $43.4 Million Private Placement Business Wire
Nov-03-14 05:00PM  GTx, Inc. To Host Third Quarter 2014 Financial Results Conference Call and Webcast Business Wire
Oct-08-14 05:00PM  GTX INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran EDGAR Online
Oct-07-14 11:40AM  The GeForce GTX 980M and 970M: NVIDIA's Efficient Maxwell Architecture Invades Mobile at Forbes
Sep-19-14 12:46PM  Nvidia's Onslaught Continues: GeForce GTX 980, GTX 970 Maxwell Cards Launched at Forbes
Sep-02-14 08:00AM  Crunching The Numbers: New AMD Radeon 285 Versus Nvidia GTX 760 at Forbes
Aug-07-14 07:30AM  GTx Announces Webcast of Corporate Presentation at the 2014 Wedbush Pacgrow Life Sciences Management Access Conference Business Wire -11.76%
Aug-05-14 07:30AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q2 2014 GTx, Inc. Earnings Release - Before Market Open CCBN
07:00AM  GTx Provides Corporate Update and Reports Second Quarter 2014 Financial Results Business Wire
Jul-22-14 07:30AM  GTx, Inc. to Report Second Quarter 2014 Financial Results on August 5, 2014 Business Wire
Jul-02-14 08:18AM  4 Biotech Stocks Under $10 to Watch for Breakout Trades at TheStreet
Jun-12-14 06:00AM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Jun-02-14 02:54PM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -14.46%
11:03AM  GTx reports results from Phase 2 study of enobosarm theflyonthewall.com
11:01AM  GTx Reports Positive Clinical Data from Open Label Phase 2 Study of Enobosarm in Patients with Androgen and Estrogen Receptor Positive Metastatic Breast Cancer Business Wire
May-29-14 06:12AM  GTX Inc. (GTXI) Soars: Stock Up 9.7% Zacks
May-22-14 07:30AM  GTx Announces Webcast of Corporate Presentation at Jefferies 2014 Global Healthcare Conference Business Wire
May-19-14 07:00AM  GTx to Present Clinical Data on Enobosarm in Breast Cancer and NSCLC at ASCO 2014 Annual Meeting Business Wire
May-12-14 05:04PM  GTx files to sell $150M of common stock, warrants at theflyonthewall.com
07:32AM  GTX INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
May-09-14 04:51PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; EDGAR Online +5.34%
May-08-14 11:08AM  GTx says current POWER trials data insufficient to support filing NDA at theflyonthewall.com -11.49%
07:32AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q1 2014 GTx, Inc. Earnings Release - Before Market Open CCBN
07:03AM  GTx reports Q1 EPS (14c), consensus (12c) at theflyonthewall.com
07:00AM  GTx Provides Corporate Update and Reports First Quarter 2014 Financial Results Business Wire
Apr-30-14 06:39AM  GTX Inc. (GTXI) Jumps: Stock Up 14.4% Zacks
Apr-29-14 08:40AM  Pitt Hyde & Mason Hawkins Buy >50% Stake In GTx Ahead Of Phase II Results at Seeking Alpha +14.39%
Apr-24-14 07:30AM  GTx, Inc. To Report First Quarter 2014 Financial Results On May 8, 2014 Business Wire
Apr-15-14 08:56AM  GTx Chief Scientific Officer James Dalton resigns at theflyonthewall.com
08:46AM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Apr-04-14 04:37PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
06:25AM  GTx Announces Departure of CEO Business Wire
Mar-25-14 01:23PM  NVIDIA announces Titan Z: a $3,000 graphics computing powerhouse at Engadget
Mar-19-14 07:47AM  Strength Seen in GTX (GTXI): Stock Moves 8.8% Higher Zacks
Mar-12-14 04:32PM  GTX INC /DE/ Files SEC form 10-K, Annual Report EDGAR Online
Mar-06-14 05:14PM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:05PM  GTx, Inc. Announces Closing of Private Placement Business Wire
Mar-05-14 08:50AM  Narrower-than-Expected Q4 Loss at GTx Zacks
07:30AM  GTx Announces Webcast of Corporate Presentation at 26TH Annual ROTH Conference Business Wire
Mar-04-14 04:17PM  GTX INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, EDGAR Online +5.95%
03:18PM  GTx's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
09:00AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
07:07AM  Q4 2013 GTx, Inc. Earnings Release - Before Market Open CCBN
07:00AM  GTx Provides Corporate Update and Reports 2013 Financial Results Business Wire
06:30AM  GTx, Inc. Announces Pricing of Private Placement Business Wire
Feb-26-14 07:30AM  GTx Announces Webcast of Corporate Presentation at Cowen and Company 34th Annual Health Care Conference Business Wire
Feb-20-14 09:08PM  Nvidia Is About To Steal The Cryptocurrency Mining Crown From AMD at Forbes
GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer and other serious medical conditions. Its lead product candidate, enobosarm (GTx-024), is in Phase 2 clinical trials for the treatment of women with advanced AR positive triple-negative breast cancer, and treatment of women with ER positive and AR positive advanced breast cancer. The company also develops Capesaris, an oral nonsteroidal estrogen receptor alpha agonist that is in Phase 2 clinical trial for secondary hormonal therapy in men with metastatic or nonmetastatic castration resistant prostate cancer. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLASS J KENNETHDirectorMay 19Buy1.2524,50030,62524,500May 20 11:50 AM
Wills Robert JamesExecutive ChairmanMay 14Buy0.9836,44035,711100,000May 14 04:29 PM
Wills Robert JamesExecutive ChairmanMay 13Buy0.889,7008,53663,560May 14 04:29 PM
Wills Robert JamesExecutive ChairmanMay 11Buy0.803,8603,08853,860May 13 10:43 AM
DOGGRELL HENRY PATTONVP, Chief Legal OfficerMay 08Buy0.8025,47720,38225,477May 11 11:22 AM
Wills Robert JamesExecutive ChairmanMay 08Buy0.8050,00040,00050,000May 11 11:22 AM
GLASS J KENNETHDirectorApr 22Buy0.7210,0007,20097,861Apr 23 04:03 PM
GLASS J KENNETHDirectorApr 21Buy0.717,6565,43687,861Apr 22 02:28 PM
GLASS J KENNETHDirectorApr 20Buy0.723,9522,84580,205Apr 22 02:28 PM
GLASS J KENNETHDirectorApr 15Buy0.723,3002,37676,253Apr 15 04:58 PM
GLASS J KENNETHDirectorApr 10Buy0.6716,40010,98872,953Apr 13 04:57 PM
HANOVER MARC STEVENInterim CEO, President and COOSep 23Buy0.755,0003,750213,138Sep 23 04:05 PM
HANOVER MARC STEVENInterim CEO, President and COOSep 17Buy0.7410,0007,432208,138Sep 17 04:06 PM
HANOVER MARC STEVENInterim CEO, President and COOAug 21Buy1.0010,00010,000198,138Aug 21 04:12 PM
HANOVER MARC STEVENInterim CEO, President and COOAug 20Buy1.0010,00010,000188,138Aug 21 04:12 PM
DOGGRELL HENRY PATTONVP, Chief Legal OfficerAug 08Buy0.9710,0009,746102,913Aug 08 04:18 PM
HANOVER MARC STEVENInterim CEO, President and COOAug 08Buy0.9510,0009,532168,138Aug 08 03:42 PM
HANOVER MARC STEVENInterim CEO, President and COOAug 07Buy0.9220,00018,348158,138Aug 08 03:42 PM
Shackelford Jason TPrin Fin. & Acct. OfficerAug 07Buy0.9210,0009,17245,263Aug 07 04:32 PM
HANOVER MARC STEVENInterim CEO, President and COOAug 07Buy0.9230,00027,606138,138Aug 07 11:19 AM